Showing results (211-220 of 438) with videos related to
Sort By:
Pageof 44
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 21, 2024
The Prognostic Nutritional Index in patients with microsatellite instability-high metastatic gastric or gastroesophageal cancers receiving immune checkpoint inhibitorsFilippo Ghelardi, Giovanni Fucà, Chiara Cavalli, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 13, 2020
Non-Operative Management Versus Total Mesorectal Excision for Locally Advanced Rectal Cancer with Clinical Complete Response After Neoadjuvant Chemoradiotherapy: a GRADE Approach by the Rectal Cancer Guidelines Writing Group of the Italian Association of Medical Oncology (AIOM)Giulia Capelli, Irene De Simone, Gaya Spolverato, et al.JCO Precision Oncology|November 7, 2024
KRASG12D-Mutated Metastatic Colorectal Cancer: Clinical, Molecular, Immunologic, and Prognostic Features of a New Emerging Targeted AlterationRoberto Moretto, Daniele Rossini, Sabina Murgioni, et al.European Journal of Cancer (Oxford, England : 1990)|June 14, 2021
Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 studyRoberto Moretto, Mirella Giordano, Anello M Poma, et al.Virchows Archiv : an International Journal of Pathology|September 19, 2021
Epstein-Barr virus associated gastric dysplasia: a new rare entity?Valentina Angerilli, Francesca Galuppini, Gianmaria Pennelli, et al.Plos One|March 10, 2018
NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patientsMarta Schirripa, Wu Zhang, Dongyun Yang, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 18, 2021
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenibMargherita Rimini, Changoon Yoo, Sara Lonardi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2018
FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant TrialAlberto Sobrero, Sara Lonardi, Gerardo Rosati, et al.BMC Cancer|July 24, 2020
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancerCarlotta Antoniotti, Beatrice Borelli, Daniele Rossini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trialCarlo Aschele, Luca Cionini, Sara Lonardi, et al.Pageof 44